# Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy

> **NCT00574405** · NA · COMPLETED · sponsor: **Arkansas Children's Hospital Research Institute** · enrollment: 24 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** MDI (split-mix NPH insulin + regular insulin or Lantus + Novolog® [or Humalog®])
- **DEVICE:** CSII (Animas Corporation insulin pump, model IR 1200)

## Key facts

- **NCT ID:** NCT00574405
- **Lead sponsor:** Arkansas Children's Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2010-03
- **Final completion:** 2011-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00574405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00574405, "Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00574405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*